Skip to main content

Advertisement

SpringerLink
Log in

Occurrence of multiple myeloma 13 years after Hodgkin’s disease: chance or consequence?

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Abrahamsen AF, Andersen A, Nome O, Jacobsen AB, Holte H, Abrahamsen AJ, Kvaloy S (2002) Long-term risk of second malignancy after treatment of Hodgkin’s disease: the influence of treatment, age and follow-up time. Ann Oncol 13:1786–1791

    Article  PubMed  Google Scholar 

  2. Cawley JC, Goldstone AH, Arno J, Rees JHK, Grant A (1974) Myeloma in a case of Hodgkin’s disease. Acta Haematol 52:349–355

    PubMed  CAS  Google Scholar 

  3. Diehl V, Franklin J, Pfreundschuh M, Lathan B, Paulus U, Hasenclever D, Tesch H, Herrmann R, Dorken B, Muller-Hermelink HK, Duhmke E, Loeffler M, German Hodgkin’s Lymphoma Study Group (2003) Standard and increased-dose BEACOPP chemotherapy compared with COPP–ABVD for advanced Hodgkin’s disease. N Engl J Med 348:2386–2395

    Article  PubMed  CAS  Google Scholar 

  4. Dorn GW, Baldwin JG Jr (1984) Rapid development of myeloma in a patient with Hodgkin’s disease. J S C Med Assoc 80:599–600

    PubMed  CAS  Google Scholar 

  5. Gherlinzoni F, Cavo M, Pileri S, Rivano MT, Boriani S, Biagini R, Emiliani E (1986) Solitary plasmacytoma of the bone in a case of Hodgkin’s disease. Acta Haematol 76:178–180

    PubMed  CAS  Google Scholar 

  6. Ibbotson RM, Revell PA, Molland EA, Minton MJ (1977) The simultaneous presentation of Hodgkin’s disease and myeloma. Postgrad Med J 53:52–53

    PubMed  CAS  Google Scholar 

  7. Mauch PM, Kalish LA, Marcus KC, Coleman CN, Shulman LN, Krill E, Come S, Silver B, Canellos GP, Tarbell NJ (1996) Second malignancies after treatment for laparotomy staged IA–IIIB Hodgkin’s disease: long-term analysis of risk factors and outcome. Blood 87:3625–3632

    PubMed  CAS  Google Scholar 

  8. Müller AMS, Ihorst G, Mertelsmann R, Engelhardt M (2005) Epidemiology of non-Hodgkin’s lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 84:1–12

    Article  PubMed  Google Scholar 

  9. Munker R, Grützner S, Hiller E, Aydemir Ü, Enne W, Dietzfelbinger H, Busch M, Haas R, Emmerich B, Schmidt M, Dühmke E, Hölzel D, Wilmanns W (1999) Second malignancies after Hodgkin’s disease: the Munich experience. Ann Hematol 78:544–554

    Article  PubMed  CAS  Google Scholar 

  10. Ng AK, Bernardo MVP, Weller E, Backstrand K, Silver B, Marcus KC, Tarbell NJ, Stevenson MA, Friedberg JW, Mauch PM (2002) Second malignancy after Hodgkin’s disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood 100:1989–1996

    Article  PubMed  CAS  Google Scholar 

  11. Sacks PV, Tavassoli M, Eastlund DT (1976) Simultaneous occurrence of myeloma and Hodgkin’s disease. Acta Haematol 55:118–122

    Article  PubMed  CAS  Google Scholar 

  12. van Leeuwen FE, Klokman WJ, Hagenbeek A, Noyon R, van den Belt-Dusebout AW, van Kerkhoff EHM, van Heerde P, Somers R (1994) Second cancer risk following Hodgkin’s disease: a 20-year follow-up study. J Clin Oncol 12:312–325

    PubMed  Google Scholar 

  13. van Leeuwen FE, Klokman WJ, van’t Veer MB, Hagenbeek A, Krol ADG, Vetter UAO, Shaapveld M, van Heerde P, Burgers JMV, Somers R, Aleman BMP (2000) Long-term risk of second malignancy in survivors of Hodgkin’s disease treated during adolescence or young adulthood. J Clin Oncol 18:487–497

    PubMed  Google Scholar 

  14. Zarate-Osorno A, Medeiros LJ, Longo DL, Jaffe ES (1992) Non-Hodgkin’s lymphoma arising in patients successfully treated for Hodgkin’s disease. Am J Surg Pathol 16:885–895

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We thank the internal reviewer in our institution. We greatly appreciate Prof. Dr. R. Mertelsmann’s continuous support, his valuable suggestions, and critical reading of the manuscript.

Author information

Authors and Affiliations

  1. St. Georg Vorsorge- und Rehabilitationskliniken, Kurhausplatz 1, 79862, Höchenschwand, Germany

    Eva-Susanne Strobel

  2. Hematology and Oncology Department, Freiburg University Medical Center, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Kris Bauchmüller & Monika Engelhardt

  3. Department of Pathology, Freiburg University, Albertstrasse 19, 79098, Freiburg, Germany

    Annette Schmitt-Gräff

Authors
  1. Eva-Susanne Strobel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kris Bauchmüller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Annette Schmitt-Gräff
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Monika Engelhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Monika Engelhardt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Strobel, ES., Bauchmüller, K., Schmitt-Gräff, A. et al. Occurrence of multiple myeloma 13 years after Hodgkin’s disease: chance or consequence?. Ann Hematol 84, 830–832 (2005). https://doi.org/10.1007/s00277-005-1097-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-005-1097-2

Keywords

Search

Navigation